Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Whoa, big buys flowing like a river
Whats going on? What’s causing the rise
Much appreciated Senti... always there for Us.
Excellent, ty much!
Set all your nwbo shares sell at $300.00 burn the shorts! Epic squeeze
Yea!!! A September to Remember!!!
BOOM!!!
3 more ahead of LP as of 10:43 PT
Me too... just feels right, timing wise.
Excellent... yes!
Excellent, the chase is on... thanks!
Jd, how are we looking now at the open?
Like what flipper said, added value. LP setting us up for an attractive package deal.
The foundation is set for BP’s to line up and swoop us up. We are the golden ticket, as Senti says we have a game changing technology.
LET THE BIDDING WAR COMMENCE !!! - after TLD ..... boom! $25+ $30+ $42!
Spot on!
Yes!!! - i’m going to Disneyland (parking lot) - this week a HUGE! Bidding war is on the way...
Great job, we have a greater chance with Cuomo.
I don’t think they’ll ramp up manufacturing if they don’t 99.9% believe they will be approve.
The word for tomorrow is CHASE. Accumulation continues and will rise up. Nothing has changed, the Trump press breakthrough is a nothing burger. Another Trump stunt to kick-off his convention. WE got more media attention, and FDA Hahn did say they are watching therapeutics on Phase 2&3.
we are set for success, many catalysts ahead of us and can't wait for partnership to be announce soon.
He also said... "This is the most exciting thing I've ever had the privilege of being involved in.” — Dr. Javitt
Boom!!! $20+
plz... will be the laughing stock of the world and the universe if that is true.
Exactly right mann! Celebrate good times c'mon... Somebody wake up "The Whale" she needs to know this now :)
i'm really thinking deep hard, what else could it be. Redemisver been taking alot of negative press and our publication was just released a few days ago... and like what Andy said:
"Aviptadil is the Only “expanded access” approved drug available today."
Plus i just added Friday before close, so hmmmmm damn I am pumped!!!
Wohoooo! Strap your seatbelts tight zoooooooooooooooooom to $20+
Yes... i believe immediate buyout after top line data.
BIG Buys coming in, chase this baby!
The word for today is Accumulate.
We go .60+ long and strong.
Excellent news!
I see it too on my schwab streamer, hmmmm
I love it, they never Learn...!!!
They’ve been in talks, should hopefully come any day.
Ameritrade charged me too, after 3 days.
What a wonderful sight it will be... In Dr Linda Liau We Trust.
Exciting times ahead of Us!
Nice! Thanks.
How can he possibly know the outcome when it is still blinded, below is a scientific journal published dated March 2020 - Phase 3: that states dcvax-L efficacy vs SOC.
"showed a 8-mo survival benefit for the addition of DCVax-L to SOC."
And the Mutation status of IDH 1 and 2 genes was not even determined yet and needed more maturation and analysis
Dated: March 2020
https://europepmc.org/article/pmc/pmc7140029
FULL Text below:
2.2.2. DC Vaccination Trials
So far, one large phase III study has investigated the therapeutic potential of DC vaccination in glioblastoma [31]. After tumor resection and chemoradiotherapy, 331 primary patients were randomized to receive either TMZ and an autologous tumor lysate-pulsed DC vaccine (DCVax-L) or TMZ plus placebo. As all patients were allowed to receive DCVax-L after tumor recurrence, there was a high crossover fraction (~90%) in this trial. The study’s primary endpoint, PFS, has not yet been evaluated and will be the subject of later analyses. The secondary endpoint, OS, has currently been analyzed for the total intention-to-treat patient population and showed a 8-mo survival benefit for the addition of DCVax-L to SOC. Mutation status of isocitrate dehydrogenase (IDH) 1 and 2 genes was not determined for this trial, which may affect clinical outcome (as IDH mutant glioblastoma patients have a better prognosis). Further maturation of the trial data is required to better assess the efficacy of DCVax-L in newly diagnosed glioblastoma.
yes it is... our time will come next month, September windfall.
Within 10 days...that next week!!!
haha, don't you know with thousands of pages of data it normally takes 4-6 weeks of tedious work. I am glad Cydy's medical experts, doctor's and the scientific board are working hard and once ready will announce our stellar results within 10 days while we load up under $5.
Boom!
I loved the conference calls, gives me insights and info on upcoming catalysts and their time frame... no worries, final results coming. Right now just adding below $5
Wow, that is 100% encouraging... and yes that is fancy. Thanks for sharing the info. Leronmilab saves lives!